ADVERTISEMENT
US Selects Two COVID-19 Vaccine Candidates for Huge Investments
US Selects Two COVID-19 Vaccine Candidates for Huge Investments
The government is assisting Johnson & Johnson and Moderna with expediting clinical testing while at the same time prepping for large-scale manufacturing.
US Selects Two COVID-19 Vaccine Candidates for Huge Investments
US Selects Two COVID-19 Vaccine Candidates for Huge Investments

The government is assisting Johnson & Johnson and Moderna with expediting clinical testing while at the same time prepping for large-scale manufacturing.

The government is assisting Johnson & Johnson and Moderna with expediting clinical testing while at the same time prepping for large-scale manufacturing.

pharma, clinical trials

Accelerate Clinical Trials with Genetic Analyses
Leveraging Genetic Drivers for Therapeutic Success
Thermo Fisher Scientific | May 2, 2022 | 1 min read
Scientists incorporate genetic analyses to streamline and accelerate clinical trials
an illustration showing amyloid plaques around brain cells
Biogen Presents Data on Efficacy of Alzheimer’s Drug
Shawna Williams | Dec 6, 2019 | 2 min read
The company and its partner halted two clinical trials for futility early this year, but now say they’ll seek approval for aducanumab.
Clinical Trial Reporting for Pharma-Sponsored Trials Shows Improvement
Diana Kwon | Dec 4, 2017 | 4 min read
The Good Pharma Scorecard finds some big pharmaceutical companies are meeting legal standards for disclosing results—but many studies still go unreported.
EMA Gearing Up for Transparency
Kerry Grens | Jun 16, 2014 | 1 min read
The European Medicines Agency is preparing for a new policy that will release rarely-seen clinical trial reports for independent scrutiny.  
Opinion: On the Up and Up
Sean E. Harper | Jun 20, 2012 | 2 min read
An Amgen executive refutes accusations that the company published misleading results of its mid-90s clinical trial testing an anemia drug.
ADVERTISEMENT